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In this scenario you are working as a practice nurse in a large GP practice. 
Your local formulary recommends morphine as the first line strong opioid analgesic.  Your practice 
pharmacist has analysed your prescribing data to check whether prescribing is in accordance with 
the formulary.  The analysis reveals that the practice is prescribing a large proportion of non-
formulary or second line strong opioids. 
In the average UK practice, morphine makes up 30% of all strong opioids prescribed.  In your 
practice, it makes up just 20% of all strong opioids prescribed. 
Your pharmacist has identified a list of 50 patients on non-formulary or second line strong opioids, 
all for chronic pain.   
Question 1 
How many of these patients would need to be reviewed and the current strong opioid converted to 
morphine, in order to match the standard of the UK average?  5 
 
Here is a sample of prescriptions from the first five patients on the list: 
 
A Oxycodone  80mg MR tablets, one twice daily  morphine 120mg twice daily 
B Oxycodone 120mg MR tablets, one  twice daily  morphine 180mg twice daily 
C Fentanyl 25microgram patch, one every 72 hours  morphine 30mg twice daily  
D Fentanyl 100 microgram patch, one every 72 hours  morphine 120mg twice daily 
e Oxycodone  40mg MR tablets, one twice daily  morphine 60mg twice daily 
 
Task 1 
Convert each of these regimens to an equivalent twice daily dose of morphine MR.  Use this table to 
help (BNF 72, 2016): 
Equivalent doses of opioid analgesics 
This is only an approximate guide (doses may not correspond with those given in clinical practice); 
patients should be carefully monitored after any change in medication and dose titration may be 
required 
Analgesic Route Dose 
Codeine PO 100 mg 
Diamorphine IM, IV, SC 3 mg 
Dihydrocodeine PO 100 mg 
Hydromorphone PO 2 mg 
Morphine PO 10 mg 
Morphine IM, IV, SC 5 mg 
Oxycodone PO 6.6 mg 
Janice Davies - Calculations question 2   
Updated 7.2.17 
Tramadol PO 100 mg 
PO = by mouth; IM = intramuscular, IV = intravenous, SC = subcutaneous 
 
72-hour Fentanyl patches are approximately equivalent to the following 24-hour doses of oral 
morphine  
morphine salt 30 mg daily ≡ fentanyl ‘12’ patch 
morphine salt 60 mg daily  ≡ fentanyl ‘25’ patch 
morphine salt 120 mg daily  ≡ fentanyl ‘50’ patch 
morphine salt 180 mg daily ≡ fentanyl ‘75’ patch 
morphine salt 240 mg daily ≡ fentanyl ‘100’ patch 
 
 
 
Based on guidance from the Faculty of Pain, your local policy recommends that patients taking high 
dose strong opioids (Greater than or equal to 120mg morphine per day for chronic non-cancer pain) 
should be reviewed because the risk of harm outweighs the benefits.    
Question 2 
How many of the above five patients should be reviewed?  4 
Question 3 
What percentage is this?  80% 
